Switching from intravenous to subcutaneous infliximab and vedolizumab in patients with inflammatory bowel disease: impact on trough levels, day hospital visits, and medical expenses-Reference-Cited by-同舟云学术

Switching from intravenous to subcutaneous infliximab and vedolizumab in patients with inflammatory bowel disease: impact on trough levels, day hospital visits, and medical expenses

Published:2023-11-25 Issue: Volume: Page:1-8
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Harno-Tasihin Jenniina¹,Siregar Laura¹,Paajanen Mikko¹,Arkkila Perttu²³,Punkkinen Jari¹⁴

Affiliation:

1. Endoscopy Outpatient Clinic, HUS, Hyvinkää Hospital, Hyvinkää, Finland

2. Department of Gastroenterology, Helsinki University Hospital, Helsinki, Finland

3. Department of Medicine, University of Helsinki, Helsinki, Finland

4. Endoscopy Unit, HUS, Jorvi Hospital, Espoo, Finland

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2023.2285229

Reference26 articles.

1. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment

2. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis

3. AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

4. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment

5. An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous versus intravenous infliximab therapy – a real-world study: toward higher drug concentrations;European Journal of Gastroenterology & Hepatology;2024-08-19

2. Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge;Journal of Clinical Medicine;2024-02-27